16 results
8-K
NBSE
NeuBase Therapeutics Inc
17 Jan 24
Departure of Directors or Certain Officers
6:15am
in his role as the Company’s Chief Financial Officer during his tenure as the Company’s interim Chief Executive Officer. Dr. Stephan is expected
8-K
EX-3.1
NBSE
NeuBase Therapeutics Inc
23 Sep 19
Amendments to Articles of Incorporation or Bylaws
5:09pm
ARTICLE V OFFICERS
Section 30.
Officers Designated
Section 31.
Tenure and Duties of Officers
Section 32.
Delegation of Authority
Section 33 … thereof to which the Board of Directors has delegated such responsibility.
Section 31. Tenure and Duties of Officers.
General. All officers shall hold
DEF 14A
5sf qsn5qvo1f
7 Mar 14
Definitive proxy
12:00am
8-K
EX-99.1
ecb5nft3qidheg5
23 May 13
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
12:00am
8-K
1ml1xv42
23 May 13
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
12:00am
8-K
EX-10.2
9mm2afl udiou7vb8s
5 Apr 07
Completion of Acquisition or Disposition of Assets
12:00am
8-K
y4tx4div4tq
5 Apr 07
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-10.3
gfynluwe
5 Apr 07
Completion of Acquisition or Disposition of Assets
12:00am
SC 14F1
wcruq
8 Mar 07
Statement regarding change in majority of directors
12:00am
- Prev
- 1
- Next